Business Operation · 2025
In this section22 topics
- Corporate Information4 items
- Dividend Policy2 items
- Major Shareholders3 items
- Business Strategies Overview5 items
- Material Changes & Developments1 item
- Use of Proceeds from Securities Offerings1 item
- Commitments Made in the Registration Statement1 item
- Group Operating-Structure Policy1 item
- Companies Where the Company Holds ≥10%1 item
- Shareholders with Potential Conflict of Interest1 item
- Relationships Among Major Shareholders1 item
- Shareholders' Agreement1 item
- Shareholding Diagram (Group Structure)3 items
- Income Structure3 items
- Product / Service Characteristics2 items
- Research & Development6 items
- Assets Used in the Business4 items
- Marketing Policy & Competition3 items
- Procurement of Products & Services6 items
- Projects Under Construction1 item
- Debentures & Bills of Exchange1 item
- Convertible Securities1 item
Corporate Information
Company Name
RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED
Telephone
1512 , 02-7439999
Website
www.ram-hosp.co.th
callcenter@ram-hosp.com
Dividend Policy
Dividend Policy
Not less than 20% of net profit (base on the separated financial statements) after deducting corporate income tax and legal reserve
Historical Dividend Payments
| This Year | Last Year | 2 Years Ago | 3 Years Ago | 4 Years Ago | Metric | Description |
|---|---|---|---|---|---|---|
| 1.09 | 0.98 | 1.22 | 1.81 | 3.48 | Net profit per share (Baht : Share) | Net profit per share (baht : share) |
| 0.1 | 0.4 | 0.9 | 0.9 | 0.72 | Dividend per share (Baht : Share) | Dividend per share (baht : share) |
| 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | Dividend stock ratio (Number of original shares: dividend shares) | Ratio of stock dividend payment (existing share : stock dividend) |
| 0 | 0 | 0 | 0 | 0 | Dividend share value per share (Baht : Share) | Value of stock dividend per share (baht : share) |
| 0 | 0 | 0 | 0 | 0 | Total dividend payment value (Baht : Share) | Total dividend payment (baht : share) |
| 9 | 41 | 74 | 49.72 | 20.69 | Dividend payout ratio to net profit (%) | Dividend payout ratio compared to net profit (%) |
Business Strategies Overview
Chairman's Message
Dear Shareholders, Service Recipients, and Partners,
Throughout its 38 years of operation, Ramkhamhaeng Hospital Public Company Limited has remained committed to delivering healthcare services with warmth and professional expertise. The Company continues to uphold high medical standards through a team of specialized physicians in order to meet the diverse healthcare needs of the public.
In 2025, the Company continued to focus on responding to the evolving landscape of the healthcare system, rapid advancements in medical technology, and the growing demand for more personalized medical services. The Group has consistently invested in modern and internationally standardized medical technologies to enhance the accuracy, safety, and effectiveness of treatments.
Notable medical innovations include intraoperative detection of parathyroid tissue, which helps preserve parathyroid glands responsible for hormone production during thyroid surgery. The introduction of Endoscopic Ultrasound (EUS) allows physicians to examine deep structural abnormalities within the gastrointestinal tract while performing endoscopy, enabling precise localization for tissue biopsy procedures.
In surgical treatment, microincision surgery has become a widely accepted standard. Ramkhamhaeng Hospital provides minimally invasive surgical services across multiple specialties, including surgery, obstetrics and gynecology, orthopedics, ear–nose–throat (ENT), and cardiovascular surgery. This approach enhances surgical precision while reducing pain, minimizing incision size, and allowing faster patient recovery compared with conventional surgery.
The Ramkhamhaeng Hospital Heart Center provides comprehensive services for cardiovascular diseases, including diagnosis, treatment, surgery, and catheter-based interventions. In 2025, the Center introduced Pulsed Field Ablation (PFA) technology for the treatment of cardiac arrhythmias, which offers higher precision and safety in eliminating abnormal electrical signals in the heart.
In response to the growing prevalence of osteoporosis and sarcopenia, particularly among the elderly and individuals with limited physical activity, the Company has introduced advanced diagnostic technologies, including DEXA Scan and Bioelectrical Impedance Analysis (BIA), to support screening and diagnosis of bone density loss and muscle mass reduction.
In cancer care, the Radiation Therapy Center at Ramkhamhaeng 2 Hospital utilizes advanced 4D radiation therapy technology, which synchronizes radiation delivery with the patient’s breathing motion. This technology improves treatment accuracy, reduces the impact on surrounding healthy tissues, and enhances safety and treatment outcomes.
The Group has also expanded cancer treatment capabilities in regional areas through the Radiation Therapy Center at Chiang Rai Ram Hospital. Meanwhile, the Vibharam Hospital Group has strengthened its medical laboratory services and Nuclear Medicine capabilities to enhance diagnostic potential across affiliated hospitals.
In addition, Vibharam Hospital Group places emphasis on providing healthcare services for insured persons under the Social Security Scheme, allowing patients to combine social security benefits with private health insurance coverage. This approach helps reduce treatment costs while expanding healthcare access for patients.
The Company also recognizes the importance of strengthening the foundation of medical education and continuously developing human resources to support future changes in medical technologies and treatment models. Key initiatives include promoting knowledge in genomic medicine, such as genetic sequencing using Next-Generation Sequencing (NGS) technology, which supports the development of personalized cancer treatment and targeted therapy. Training programs have also been conducted in collaboration with international experts from Mayo Clinic, USA, particularly in the field of cardiopulmonary rehabilitation and the use of Cardiopulmonary Exercise Testing (CPET). In addition, the Company promotes knowledge management and multidisciplinary treatment approaches to enhance comprehensive patient care.
In driving the organization through digital innovation, the Company continues its Digital Transformation toward becoming a Smart Hospital. This includes the development of integrated patient information management systems and the RAM Health Mart application, which facilitates patient access to treatment information and healthcare services. The Company has also developed new systems that enable effective data connectivity among affiliated hospitals and is preparing to integrate Artificial Intelligence (AI) technologies to support patient data management, improving accuracy, safety, and operational efficiency.
Beyond continuously improving medical services, the Company also places great importance on enhancing patient experience and comfort. Various facility improvements have been undertaken, including the expansion of service areas in new buildings, renovation of patient rooms to provide modern and comfortable environments, and upgrades to examination rooms and supporting facilities such as waiting areas, restaurants, convenience stores, and valet parking services for the convenience of all visitors.
The Board of Directors remains committed to overseeing the Company’s operations in alignment with its strategic goals, strengthening the organization’s capabilities and readiness to meet the healthcare needs of people across all regions, while supporting the Company’s stable and sustainable growth.
On behalf of the Board of Directors, I would like to express my sincere appreciation to all shareholders, service recipients, and partners for your continued trust and support. I would also like to thank our doctors, nurses, and all personnel whose dedication is the key driving force behind Ramkhamhaeng Hospital’s continued growth. The Company will continue to uphold good corporate governance while advancing medical technology and standards to create sustainable value for Thai society.
Dr. Pitchaya Somburanasin, M.D.
Chairman of the Group Executive Committee
Ramkhamhaeng Hospital Public Company Limitedd
Vision
Aiming to be Thailand’s leading health network, delivering international medical standards accessible to everyone , growing sustainably alongside Thai society.
Objectives
To connect and manage an integrated health network to deliver international-standard healthcare, through the integration of expertise, innovation, and long-term health partnerships.
Goals
-
Business Strategies
Focus on Clinical ExcellenceAttract and retain best-in-class talent to deliver strong patient outcomes. Invest in technology and digital.
Flagship hospitals driven growthCapacity expansion (RAM 2, THG 2), optimize procedure-mix and ALOS;
New COEs. Optimize support function.Commitment to ESG and sustainabilityCorporate governance, social responsibility and risk management.
Optimize Existing AssetsImprove occupancy; cross-referral, Rebalance case mix; right-size cost structure; Divest non-core assets.
Prudent Capital ManagementFocus on cash flow, reduce leverage and prioritize high ROCE projects; streamline and rationalize investments.
Expand Hospital Network
Brownfield expansion, mergers & acquisitions and partnerships
Material Changes & Developments
Material Changes & Developments
| Year | Description |
|---|---|
| 2,025 |
|
| 2,024 |
|
| 2,023 |
|
Use of Proceeds from Securities Offerings
Is There Money Raised from a Securities Offering Still to Report On?
No
Commitments Made in the Registration Statement
Are There Commitments or Conditions from an Offering or Listing?
No
Group Operating-Structure Policy
Description
The Company has a policy to invest in subsidiaries and associates within the private hospital business, considering that such companies are likely to achieve favorable performance in the future.
with the expectation of returns in the form of dividends. The Company tends to invest in available-for-sale securities that offer an average dividend yield exceeding the market interest rate.
Companies Where the Company Holds ≥10%
Companies (≥10% Holding)
| Company Name | Address | Province | Zip Code | Telephone | Fax | Business Type | Security Type | Shares | Paid-up Shares |
|---|---|---|---|---|---|---|---|---|---|
| Chaiyaphum-Ram Hospital Company Limited | 290/42 Chaiyaphum-Sikhio Road, Nai Mueang Subdistrict, Mueang District, Chaiyaphum Province 36000 | Chaiyaphum | 36000 | - | - | Private Hospital | Common shares | 4,606,510 | 5,880,000 |
| Mueang Loei Ram Hospital Company Limited | 546 Moo 1 Maliwan Road, Na An Subdistrict, Mueang District, Loei Province 42000 | Loei | 42000 | - | Private Hospital | Common shares | 32,213,400 | 41,473,500 | |
| Vientiane-Ram International Hospital Company Limited | Vientiane, Laos | - | Private Hospital Under Construction | Common shares | 1,750,000 | 7,150,000 | |||
| Nan Ram Hospital Company Limited | 553 Moo 4, Chaiyathan Sub-district, Mueang Nan District, Nan Province | Nan | - | Private Hospital is under operation | Common shares | 41,960,000 | 80,000,000 | ||
| Ramnakara Company Limited | 119/129-132 Nawamin Road, Nawamin Sub-district, Bueng Kum District, Bangkok 10240 | Bangkok | 10240 | - | Private Hospital | Common shares | 26,879,785 | 45,000,000 | |
| Vibharam Hospital Company Limited | 2677 Phatthanakan Road, Suan Luang Sub-district / District, Bangkok 10250 | Bangkok | 10250 | - | Private Hospital | Common shares | 100,000,000 | 200,000,000 | |
| R Plus Asset Company Limited | Phetchaburi Road, Bangkok | Bangkok | - | Private Hospital under construction | Common shares | 15,624,999 | 31,250,000 | ||
| M.I. Calibration System Company Limited | 94 Soi Ramkhamhaeng 32 (Wiset Suk), Huamark Subdistrict, Bangkapi District, Bangkok | Bangkok | - | Sales of Medical Devices | Common shares | 2,199,999 | 2,200,000 | ||
| Mahasarakham Ram Hospital Company Limited | 118 Nakhon Sawan Road, Talat Sub-district, Mueang Maha Sarakham District, Maha Sarakham Province | Mahasarakam | - | Private Hospital under construction | Common shares | 1,200,000 | 2,006,260 | ||
| Vacharasirivet Company Limited | 123 Moo 26, Phahonyothin Road, Rob Wiang Subdistrict, Mueang Chiang Rai District, Chiang Rai 57000 | Chiang Rai | 57000 | - | Private Hospital | Common shares | 2,886,500 | 7,170,000 | |
| Legacy Golf (Thailand) Company Limited | 18 Moo 7, Liap Khlong Song Road, Sam Wa Tawan Ok Subdistrict, Khlong Sam Wa District, Bangkok 10510 | Bangkok | 10510 | - | Golf Course | Common shares | 105,000,000 | 210,000,000 | |
| Phayao Ram Hospital Company Limited | 660 Moo 3, Tha Wang Thong Sub-district, Mueang District, Phayao Province 56000 | Phayao | 56000 | - | Private Hospital | Common shares | 6,300,000 | 15,750,000 | |
| Thonburi Rangsit Hospital Company Limited | 61/160 Rama 9 Road, Huai Khwang Sub-district, Huai Khwang District, Bangkok 10310 | Bangkok | 10310 | - | Private Hospital | Common shares | 3,999 | 10,000 | |
| Buriram Ruamphat Co., Ltd. (Buriram-Ram Hospital) | 197 Moo 2, Buriram-Phutthaisong Road, Chum Het Sub-district, Mueang District, Buriram Province 31000 | Buriram | 31000 | - | Private Hospital | Common shares | 3,067,405 | 8,500,000 | |
| Piyasiri Company Limited (Sukhumvit Hospital) | 316/32 Soi Sukhumvit 22, Sukhumvit Road, Khlong Toei District, Bangkok 10110 | Bangkok | 10110 | - | Private Hospital | Common shares | 602,624 | 1,760,000 | |
| Rangsiphan Company Limited | 170-172/1 (2nd, 3rd Floor) Boriphat Road, Ban Bat Subdistrict, Pom Prap Sattru Phai District, Bangkok 10100 | Bangkok | 10100 | - | Sales and Repair of Medical Devices | Common shares | 3,000 | 10,000 | |
| Synphaet Nakhon Pathom Company Limited | 1298 Phetkasem Road, Lam Phaya Subdistrict, Mueang Nakhon Pathom District, Nakhon Pathom 73000 | Nakorn Phathom | 73000 | - | Private Hospital | Common shares | 30,000,001 | 100,000,000 | |
| Synphaet Company Limited | 9/99 Ramintra Road, Km. 8.5, Khwaeng/Khet Kannayao, Bangkok | Bangkok | - | Private Hospital | Common shares | 32,948,889 | 116,000,000 | ||
| Renal Serve Company Limited | 719 KBM Building, Unit D1, 19th Floor, Rama IX Road, Bang Kapi Subdistrict, Huai Khwang District, Bangkok 10310 | Bangkok | 10310 | - | Medical devices and supplies | Common shares | 570,000 | 3,000,000 | |
| Buranawej Company Limited (Phetcharat Hospital) | 2/1 Samakkhi Thai Road, Nai Mueang Sub-district, Mueang District, Phetchabun Province 67000 | Phetchabun | 67000 | - | Private Hospital | Common shares | 1,342,127 | 7,500,000 | |
| Khon Kaen Ram Hospital Company Limited | 193 Srichan Road, Mueang District, Khon Kaen Province 40000 | Khon Kaen | 40000 | - | Private Hospital | Common shares | 1,312,200 | 8,000,000 | |
| Synphaet Serirak Company Limited | 44 Seri Thai Road, Min Buri Sub-district, Min Buri District, Bangkok 10510 | Bangkok | 10510 | - | Private Hospital | Common shares | 2,000,000 | 12,200,000 | |
| Poompanya International Co., Ltd. | 50 Huay Kaew Road, Chang Phueak Subdistrict, Mueang Chiang Mai District, Chiang Mai 50300 | Chiang Mai | 50300 | - | Educational Institution | Common shares | 980,000 | 6,000,000 | |
| Viphawadi Hospital Public Company Limited | 51/3 Ngamwongwan Road, Lat Yao Sub-district, Chatuchak District, Bangkok 10900 | Bangkok | 10900 | - | Private Hospital | Common shares | 1,526,648,333 | 13,576,011,474 | |
| Sahaphat Phesat Company Limited | 450 Soi Rama 2 Soi 50, Samae Dam Sub-district, Bang Khun Thian District, Bangkok 10150 | Bangkok | 10150 | - | Dispensing Medicine | Common shares | 430,000 | 4,286,000 | |
| Synphaet Pattanakarn Company Limited | 508 Ramintra Road, Ramintra Subdistrict, Kannayao District, Bangkok 10230 | Bangkok | 10230 | - | Private Hospital | Common shares | 5,000,000 | 50,000,000 | |
| Chiangmai Ram Hospital Company Limited | 8 Boonruangrit Road, Si Phum Subdistrict, Mueang District | Chiang Mai | 50200 | 052004699 | Private Hospital | Common shares | 17,156,667 | 40,000,000 | |
| Thonburi Healthcare Group Public Company Limited | 34/1 Itsaraphap Road, Ban Chang Lo, Bangkok Noi | Bangkok | 10700 | 024872000 | Private Hospital | Common shares | 1,789,154,360 | 1,789,154,360 |
Income Structure
Product / Service Income
| Category | Description | This Year | This Year % | Last Year | Last Year % | 2 Years Ago | 2 Years Ago % |
|---|---|---|---|---|---|---|---|
| Total revenue from operations | Total revenue from operations | 14,771,619.04 | 100 | 9,867,598.3 | 100 | 9,634,130.28 | 100 |
| Medical Treatment Revenue | 13,339,427.82 | 90.3 | 8,965,308.94 | 90.86 | 8,542,323.18 | 88.67 | |
| Revenue from sales of medical devices and medical supplies | 1,135,798.58 | 7.69 | 902,289.36 | 9.14 | 1,091,807.08 | 11.33 | |
| Revenue from Services (Medical and Other Services) | 278,880.52 | 1.89 | 0 | 0 | 0 | 0 | |
| Other | Others | 17,512.12 | 0.12 | 0 | 0 | 0 | 0 |
Export Income
| Category | Description | This Year | This Year % | Last Year | Last Year % | 2 Years Ago | 2 Years Ago % |
|---|---|---|---|---|---|---|---|
| Total revenue | Total revenue | 14,771,619.04 | 100 | 9,867,598.3 | 100 | 9,634,130.28 | 100 |
| Domestic | Domestic | 14,771,619.04 | 100 | 9,867,598.3 | 100 | 9,634,130.28 | 100 |
| International | International | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income
| Operating Other Income | Non-Operating Other Income | Share of Profit |
|---|---|---|
| 1710 · As of year: 2022546.68 · Description: Total other income · As of yesteryear: 361088.24 · As of year before yesteryear: 699604.94 · 1711 · As of year: 0.0 · Description: Other income from operations · As of yesteryear: 0.0 · As of year before yesteryear: 0.0 | 1712 · As of year: 2022546.68 · Description: Other income not from operations · As of yesteryear: 361088.24 · As of year before yesteryear: 699604.94 | 1713 · As of year: 673993.0 · Description: Share of profit · As of yesteryear: 56809.44 · As of year before yesteryear: 707724.44 |
Product / Service Characteristics
Business Type
3114
Business Groups
| Business Group | Description | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Business of operating a medical facility |
Ramkhamhaeng Hospital Public Company Limited Group operates private hospitals, providing comprehensive medical services by specialist physicians in all fields, experienced personnel, and modern medical equipment to general patients and patients under government health welfare schemes, such as patients under the Social Security Scheme (SSO) and patients under the National Health Security Office (NHSO) schemes, for both outpatients and inpatients. The total registered bed capacity is over 8,301, with 8,101 beds in Thailand and 200 beds abroad. 1.1) Domestic Healthcare Business Private hospitals in Bangkok and its vicinity, totaling 10 hospitals Ramkhamhaeng Hospital Group
Viphaporn Hospital Group
Thonburi Hospital Group
Private hospitals in other provinces, totaling 12 hospitals Ramkhamhaeng Hospital Group
Viphaporn Hospital Group
Thonburi Hospital Group
Chiangmai Ram Hospital Group
1.2) International Healthcare Business This business, under the THG Group, has partnered with local ally Ga Mone Pwint Company Limited ("GMP"), a renowned retail and real estate developer in Myanmar, to establish a joint venture for operating an international standard hospital in Myanmar named Ar Yu International Hospital. It began providing services initially for outpatients in September 2018 and fully opened on March 17, 2019. Currently, it has 200 beds and 37 examination rooms and has received JCI (Joint Commission International) accreditation. 1.3) Medical Service Outsourcing Business THG has gained the trust of local administrative organizations to manage hospitals for public hospitals seeking to enhance management efficiency. The Company has entered into a service contract to manage and operate one hospital under a local administrative organization, namely a Sub-district Health Promoting Hospital (Tambon Health Promoting Hospital) in Phuket Province. 1.4) Specialized Medical Center Business THG recognized the growth potential of the specialized medical center business and thus established Thonburi Sermrat Company Limited (formerly Thonburi Hospital Heart Center Company Limited). This company operates by contracting to manage heart centers for both public and private healthcare facilities, providing renowned specialist cardiologists for comprehensive care. It has undertaken three heart disease medical service outsourcing projects, namely:
Thonburi Sermrat Company Limited commenced operations on April 17, 2018, and received approval from the National Health Security Office to treat patients under the universal healthcare scheme on October 1, 2018.
Thonburi Sermrat Company Limited signed an academic cooperation agreement to manage the Heart Center for Panyananthaphikkhu Chonprathan Medical Center (formerly Chonprathan Hospital) under Srinakharinwirot University. This cooperation agreement expired in March 2025. The company is currently awaiting the results of the bidding process to renew the service contract. The objective is to ensure that the Heart Center, with its team of specialized expert physicians, can continue to provide services in conjunction with Panyananthaphikkhu Chonprathan Medical Center or as part of public services continuously and with maximum efficiency.
The Company has integrated digital technology into its healthcare services, enhancing the accuracy and speed of diagnosis and treatment. This enables the delivery of new medical services that align with contemporary lifestyles, ensuring high-quality medical care and a positive experience for all service users. Ramkhamhaeng Hospital has developed an electronic patient information management system (Hospital Information System) and various applications to facilitate fast, accurate, and safe patient care. This also allows patients and service users to access their treatment information, view details of hospital services, receive self-care knowledge, and important medication details, as well as schedule appointments with doctors and conveniently purchase medical equipment and hospital medical services. The aim is for Ramkhamhaeng Hospital to truly be a smart hospital for all patients. Furthermore, the Company has developed a system to connect healthcare databases among network hospitals that share a common system. This facilitates convenience when patients seek treatment at different hospitals, allowing doctors to access useful medical history information for care, while prioritizing the highest level of data security and patient privacy. To cater to the lifestyle of the new generation, the Company has expanded online communication channels, including the hospital's website and social media platforms, as well as leading online forums in Thailand such as Facebook, Line, and Pantip.com. These platforms provide beneficial health information, introduce and communicate various medical services of the hospital, and serve as a channel for contacting and providing information to patients and those interested in the hospital's services. Additionally, they enhance access to online medical products and health services through the Ram Market Place online store and other online marketplaces such as Lazada, Shopee, etc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (2) Business of selling medical devices, pharmaceuticals, and medical supplies, and providing medical device calibration services (M.I.CAL.SYSTEM) | Ramkhamhaeng Hospital Public Company Limited has a department for procuring quality medical equipment, medical supplies, and laboratory systems directly from manufacturers for use in its own hospital and its network hospitals. It can also distribute these to other hospitals, both public and private. The large volume of orders for multiple hospitals provides significant bargaining power and helps network hospitals effectively control costs for essential equipment, medical supplies, and laboratory systems. Due to the continuous growth of the M.I.CAL.SYSTEM business, and to ensure clarity in efficient business operations, on March 13, 2023, the Company established M.I. Calibration System Company Limited as a subsidiary, with the Company holding 99.99% of its shares. This subsidiary was established to engage in the business of selling medical instruments, laboratory diagnostic supplies, and medical instrument calibration services to the Company, its affiliates, and third parties. The business of selling medical instruments, pharmaceuticals, and medical supplies, and providing medical instrument calibration services (M.I.CAL.SYSTEM) continued to generate revenue for the company in 2025. In 2025, the Company had a total revenue of 1,424 million Baht. Sales revenue accounted for 95%, and service revenue accounted for 5%, representing an increase of 9.63% from the previous year. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (3) Pharmaceutical and Medical Supplies Sales Business | The Company has co-invested in joint ventures engaged in the sale of medical devices and supplies, with experience in manufacturing, importing, distributing pharmaceuticals, medical supplies, dialysis solutions, and providing medical device repair services, namely:
These 5 companies will sell and provide services to affiliated hospitals at special prices, lower than those offered to general hospitals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (4) Service Business | The Company, under Thonburi Group, is the first private hospital entrusted by local administrative organizations to manage hospitals in collaboration with public hospitals seeking to enhance management efficiency. Currently, Thonburi Healthcare Group Public Company Limited and its affiliates, operating under the name Thonburi Sermrat Company Limited, have entered into service agreements to manage and operate three hospitals under local administrative organizations and sub-district health promoting hospitals, namely:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (5) Investment in Associate Companies and Subsidiaries | In addition to the hospital business and the sale of medical devices, pharmaceuticals, and medical supplies, the Company identifies opportunities to invest in associates and other companies, including hospital businesses, hospital-related businesses, and other ventures. The Company consistently receives annual dividend returns from the performance of these invested companies. As of December 31, 2025, the Company's dividend income amounted to 258.15 million Baht. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research & Development
Has R&D Policy (Y/N)
No
R&D Cost — Description
-
R&D Cost — Label
Research and development (R&D) expenses over the past 3 years (Million Baht)
R&D Cost — This Year
0.0
R&D Cost — Last Year
0.0
R&D Cost — 2 Years Ago
0.0
Assets Used in the Business
Permanent Assets — Description
Assets used in the business operations of the Company and its subsidiaries, intended for normal business operations of the organization as of December 31, 2025.
Key fixed assets
Assets | Nature of ownership | Ramkhamhaeng PCL | Subsidiary | Total |
Land | Owned | 836 | 9,344 | 10,180 |
Land improvement | Owned | 6 | 55 | 61 |
Buildings and improvements | Owned | 343 | 8,998 | 9,341 |
Building and improvement | Owned | - | 2,633 | 2,633 |
Medical equipment | Owned | 263 | 2,444 | 2,707 |
Office equipment | Owned | 24 | 357 | 381 |
Furniture and fittings | Owned | 6 | 754 | 760 |
General equipment | Owned | 16 | 2 | 18 |
Vehicles | Owned | 17 | 111 | 128 |
Owned | 127 | 4,492 | 4,619 | |
Total land, buildings, and equipment - net | 1,638 | 29,190 | 30,828 | |
Note: -
Right-of-use assets
Right-of-use assets | Type of ownership | Ramkhamhaeng PCL | Subsidiary | Total |
Land | Right to use under contractual terms | - | 1,794 | 1,794 |
Buildings | Right to use under contractual terms | - | 34 | 34 |
Medical equipment | Right to use under contractual terms | - | 3 | 3 |
Furniture and fixtures | Right to use under contractual terms | - | 8 | 8 |
Computer equipment | Right to use under contractual terms | - | 3 | 3 |
Vehicles | Right to use under contractual terms | - | 6 | 6 |
Total right-of-use assets | - | 1,847 | 1,847 | |
Significant land use rights are subject to the following conditions:
On July 22, 2021, the Company and the joint venture entered into an agreement to obtain lease rights with Rajamangala University of Technology Krungthep. The Company paid land lease rights totaling 52 million Baht, and the joint venture has the right to construct buildings on the leased area. Upon termination of the agreement, it was agreed to transfer ownership of all buildings and their appurtenances to Rajamangala University of Technology Krungthep. The agreement stipulates a construction and land development period of 3 years, from January 20, 2022, to January 19, 2025, with no rent payable. Upon completion, the joint venture will enter into a land lease agreement for a period not exceeding 30 years, with an annual rent of 3.2 million Baht and a 10% rent increase every 5 years.
On September 18, 2023, the Company and its subsidiary no longer wished to co-invest in the joint venture. Therefore, a memorandum of understanding was executed to transfer the right to enter into a lease agreement with Rajamangala University of Technology Krungthep to the co-venturer, and the co-venturer was appointed to find new investors to join the project. Consequently, the Company recorded a gain from the termination of the lease agreement amounting to 12.43 million Baht in the statement of comprehensive income. Regarding the 52 million Baht that the Company had paid to Rajamangala University of Technology Krungthep, the co-venturer agreed to repay this amount to the Company, and it has been presented under other non-current assets in the statement of financial position.
On November 14, 2024, Rajamangala University of Technology Krungthep sent a letter of contract termination to the joint venture, stating that from the date of signing the contract until now, which marks the completion of the 3-year period, the joint venture has not carried out any construction in accordance with the contract. Although the joint venture has sent several letters of clarification and dispute, Rajamangala University of Technology Krungthep insists on terminating the contract with the joint venture. Currently, the joint venture has filed a lawsuit against Rajamangala University of Technology Krungthep to reclaim the land lease rights fee of 52 million Baht. The Company has already recorded an expected credit loss allowance of 52 million Baht in its financial statements.
On June 1, 2020, a subsidiary entered into a land lease agreement for 13,749 square meters in Vientiane, Laos, for a period of 30 years, from June 1, 2020, to May 31, 2050, with an option to renew. The company's management considers the right-of-use land to be amortized over a period of 60 years. Additionally, the company is required to pay an annual rent of USD 100,000.
Intangible Assets — Description
-
Intangible assets
|
Assets |
Ownership type |
Ramkhamhaeng PCL
|
Subsidiary
|
Total
|
|
Computer software |
Owned |
259 |
280 |
|
|
Computer software under installation |
Owned |
- |
15 |
15 |
|
Customer relationships |
Owned |
- |
42 |
42 |
|
Less Allowance for impairment |
- |
(7) |
(7) |
|
|
Total intangible assets |
309 |
330 |
||
Has Subsidiaries Investment Policy (Y/N)
Yes
Subsidiaries Investment Policy — Description
The Company has a policy to invest in subsidiaries and associates operating in the private hospital business, considering that such companies are likely to achieve favorable performance in the future, with the expectation of returns in the form of dividends. The Company tends to invest in available-for-sale securities that provide an average dividend yield exceeding the market interest rate.
Marketing Policy & Competition
Reporting Mode
3117
Marketing Policy (Overall)
Hospitals operated by joint ventures and subsidiaries
Hospitals within the network of joint ventures and subsidiaries systematically coordinate patient referrals (Referral System). Patients can be referred to network hospitals for continued treatment in cases where complex medical conditions require care beyond the originating hospital's capacity, or for continuous care during recovery. This is to facilitate and enhance the quality of services provided to patients.
In addition, the aforementioned referral system also contributes to supporting the efficient utilization of resources within the network and strengthens the overall hospital network. Furthermore, the company also generates income in the form of dividends from investments in joint ventures and subsidiaries.
Industry & Competition (Overall)
Industry Overview and Competition
In 2025, the private hospital business in Thailand is projected to maintain continuous growth, with the opening of additional new private hospitals, particularly in major urban areas and tourist destinations experiencing continuous economic expansion.
Thailand is fully transitioning into an aging society. Coupled with the rising average life expectancy of the population, this significantly increases the demand for treatment of chronic and complex diseases. This trend supports the growth of hospitals within the social security system.
In the long term, the competitive landscape of the private hospital business will shift towards network-based competition. Hospital groups with networks and medical partnerships will gain an advantage through patient referrals, shared resource utilization, and the transfer of medical knowledge, as well as efficient cost management.
Concurrently, digital technology continues to play a crucial role (digital disruption). Hospitals that invest in developing digital systems, including internal operating systems, patient data management, and service connectivity from pre-treatment, during treatment, and post-treatment, as well as Telemedicine services, will be able to enhance patient access, create opportunities for revenue expansion, and effectively strengthen their adaptability to changing situations.
Procurement of Products & Services
Reporting Mode
3117
Procurement (Overall)
-
Medical personnel
Physicians are a crucial factor for the hospital business. Ramkhamhaeng Hospital and its network hospitals have sufficient specialized physicians to provide services in each treatment department, while nurses and other medical personnel possess extensive experience in patient care. The recruitment and selection of medical personnel are conducted under the consideration of the Medical Director and rely on a referral system to ensure experienced and qualified personnel. Furthermore, Ramkhamhaeng Hospital and its network hospitals have a long-standing reputation and credibility, which continuously attracts medical personnel interested in employment.
-
Medicines and medical supplies
Most procurement of medicines and medical supplies is conducted through local market suppliers, as these are generally available products with numerous suppliers. However, for certain types of treatments, hospitals also need to procure additional medicines and medical supplies from abroad. Currently, despite the presence of major suppliers in the market, there is no monopoly by any single supplier. This allows the hospital group to select quality suppliers and manage costs efficiently. Furthermore, the hospital group prioritizes quality control, safety standards, and continuity of supply to effectively support medical services.
-
Medical equipment and instruments
The Company has established a dedicated business unit to oversee the procurement of medical equipment and instruments, as well as maintenance. This is carried out both through internal departments and directly through distributors or medical device manufacturers.
The Company selects modern medical tools and equipment, sourcing them from abroad, such as China, Korea, Germany, and the United States, or through distributors in Thailand, to ensure the quality and standards of medical care. This business unit not only supports the needs of the Company and its subsidiaries but also provides procurement services to partner hospitals within the network. This enables the Company to plan procurement in advance, increase bargaining power with suppliers, and achieve cost efficiency, coupled with receiving quality after-sales services, thereby enhancing the overall resource management efficiency of the group.
Raw Material Acquisition (Overall)
-
Medical Service Pricing
The Company's medical service pricing is primarily determined by customer groups, which can be divided into two main categories as follows:
-
General Customer Group
This includes self-paying customers, contractual customers, and customers utilizing health insurance benefits. Pricing is primarily based on physician fees, service costs, medical supplies, and related medical equipment. Furthermore, the Company considers the complexity of the treatment and the appropriateness of pricing for service recipients in each area.
Additionally, for certain services with relatively fixed costs, the Company offers package pricing (e.g., childbirth and annual health check-ups) to facilitate easier and faster decision-making for service recipients.
-
Customer groups under social security and universal healthcare schemes
Medical service fees for this group are in accordance with rates stipulated by government agencies, namely the Social Security Office and the National Health Security Office, with the following primary payment models:
-
Capitation service fees (payment for services based on the number of eligible individuals registered with the hospital
-
Non-capitation fees include services for high-risk diseases (e.g., outpatient services for certain chronic diseases) and inpatient services for high-cost diseases, which are determined by the relative weight of the treatment (
These service fees will be based on actual services rendered, within the budget and conditions stipulated by the relevant agencies.
Production Policy (Overall)
As of December 31, 2025, the hospitals under the Company and its subsidiaries have a registered capacity of 3,626 beds, ready to serve general patients and patients under government health welfare schemes. As of December 31, 2025, Vibharam Hospital Group has an average of 490,749 insured persons under the social security scheme.
The full production capacity details of the Company and its subsidiaries are divided into 4 main groups, as follows:

Production Capacity (Overall)
| Item | Unit | Unit (if Other) | Used | Capacity |
|---|---|---|---|---|
| Ramkhamhaeng Hospital | Others | Bed | 43.78 | 1,709 |
Domestic/Overseas Purchase Proportion (Overall)
| Raw Material | Source Country | Value |
|---|---|---|
| Medicines and Medical Supplies | Thailand | 479,726.61 |
Projects Under Construction
Has Projects Under Construction (Y/N)
No
Debentures & Bills of Exchange
Has Debentures (Y/N)
No
Convertible Securities
Has Convertible Securities (Y/N)
No

